Join
This site is intended for healthcare professionals
1
Role of Post-Exposure Prophylaxis in COVID-19
2
Screens Driving Horrific Harm to Children’s Health
3
Gut Microbiome Predicts Response to Diabetes Drugs
4
EMJ Innovations 10.1 2026
5
Stem-Cell Therapy Success in China Marks Milestone in Type 1 Diabetes Treatment
Advanced Maternal Age and Childhood Allergy Risk
Simple Fitness Test Predicts Pulmonary Hypertension Outcomes
Photoprotection May Preserve Epigenetic Stability in Human Skin
Acute Pancreatitis Warnings Strengthened on GLP-1RAs
Scalable chikungunya vaccine breakthrough
EMJ’s Latest Flagship Journal
AI Models Combine Genomics and Demographics to Predict Gastric Cancer Risk
Ramadan Fasting Reveals What Sustains Change in Dietary Behavior
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
Rollout of AI Scribe Tools Transform NHS Consultations
Nomogram Predicts Atrial Fibrillation Recurrence After Cryoballoon Ablation
Mullein Leaf Extract Shows Antibacterial Promise
SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes
Cenobamate Impact on Cognition in Tuberous Sclerosis Complex
AI System Improves MRI Breast Cancer Diagnosis
MRI Radiomics May Help Stratify Rectal Cancer Risk
Sleep Quality Linked to Favourable ART Outcomes
Key Predictors of Death in Septic Shock Identified
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
Low Midlife PSA Linked to Reduced 20-Year Prostate Cancer Risk